Tech
Now that digital therapeutics have Medicare coverage, the real test begins
After years of financial instability, there’s a path to payer coverage for this new field.
After years of financial instability, there’s a path to payer coverage for this new field.
Don’t call it a comeback.
Mood may meet its match with AI.
If you know anyone with schizophrenia, prediabetes, or low bone density, the FDA is on the ball.
Symptoms like fatigue and loss of smell and taste are more common among younger patients, according to Northwestern Medicine.
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.